Advertisement
Screener

Adamant Biomedical Investments AG Current Holdings: Foreign Stocks

Adamant Biomedical Investments AG current holdings: Foreign Stocks

Adamant Biomedical Investments AG reported $0.01 billion in share positions in stocks (depositary receipts and foreign shares traded over the counter), 2 positions, in its Form 13F for the quarter ended 2014-12-31; the largest are TEVA, RDY.

  • TEVA: Country of operation —; Class ADR; Shares 50,000; Value $2,876,000.
  • RDY: Country of operation —; Class ADR; Shares 50,000; Value $2,522,000.

Form 13F-HR as filed (SEC CIK 1542336): quarter ended 2014-12-31, filed 2015-02-13. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.

Performance is each holding's price change from its close on the 2014-12-31 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.

StockCountry of operationClassSharesValue% of listedQuarter endFiledPerformance
TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR50,000$2,876,0001.29%2014-12-312015-02-13-30.78%
RDY
DR REDDY'S LABORATORIES LIMITED
ADR50,000$2,522,0001.13%2014-12-312015-02-13+27.35%

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet